Pharming receives FDA priority review for leniolisib in children with APDS

Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m

Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe

Vicore Pharma's buloxibutid receives orphan drug designation in Japan

Novartis to launch US direct-to-patient platform for Cosentyx

Genmab to acquire Merus in USD8bn all-cash deal

Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI

Johnson & Johnson secures FDA approval for TREMFYA for paediatric plaque psoriasis and active psoriatic arthritis

Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline

Sen-Jam Pharmaceutical and KVK Tech complete final development deliverables for SJP-002C

AbbVie submits NDA to FDA for tavapadon in Parkinson's disease

Eli Lilly receives US FDA approval for Inluriyo

Eli Lilly receives European marketing authorisation for Kisunla in early symptomatic Alzheimer's disease

Biostar Pharma gains FDA orphan drug designation for Utidelone in pancreatic cancer

Corstasis and U.S. Heart and Vascular partner to advance heart failure care with ENBUMYST